Company facts
- Founded
- 1996
- Employees
- 50
- Headquarters
- United States
- Type
- Private
About
CXL (corneal collagen-cross-linking) is a relatively new ophthalmic treatment that uses UV-light and riboflavin to create biochemical and biomechanical changes that strengthen a compromised or diseased cornea. Initially developped for the traitement of corneal degeneration (keratoconus), recent reports indicate that CX…